Skip to Content

Tag: oral pill


Also Noted

Apnimed backs OSA pill with two new peer-reviewed articles

May 19, 2026HME News Staff

CAMBRIDGE, Mass. – Apnimed has published two peer-reviewed articles on AD109 (aroxybutynin 2.5 mg/atomoxetine 75 mg), an investigational, once-daily oral pill taken at bedtime designed to improve oxygenation and target the neuromuscular root cause of obstructive sleep apnea (OSA). The Phase 3 SynAIRgy trial results are published in the American Journal of Respiratory and Critical Care Medicine (AJRCCM), alongside a companion mechanistic review article in the American Journal of Respiratory...

Apnimed, CPAP Alternative, Obstructive Sleep Apnea (OSA), oral pill


Read Full Articlered right arrow icon